Skip to content
Recall Observatory FDA recall evidence

Drug product

Glipizide 2.5 mg Extended-release tablets, 30-count bottle, Rx Only, Manufactured By: Patheon Pharmaceuticals Inc Cincinnati, OH 45237, NDC 00591-0900-30

D-1457-2016

June 30, 2016

Class II

Product summary

Firm
Actavis Inc
Event
Event 74702
Status
Terminated
Classification
Class II
Quantity
167,152 bottles
Official record key
drug-enforcement:D-1457-2016

Official wording

Reason: Failed Dissolution Specifications: Glipizide 2.5 mg ER Tablets exceeded dissolution specification rates for the 10 hour testing point.

Code information: Lot # 3132593, 3132594, 3134420, 3134421,3134422, Exp. 02/17

Distribution pattern: Nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Dissolution Specifications

Field note

Send feedback

We'll only use this to respond to your feedback.